Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts

This publication has 51 references indexed in Scilit:

• Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
  Annals of the Rheumatic Diseases, 2012
• Largazole and Analogues with Modified Metal-Binding Motifs Targeting Histone Deacetylases: Synthesis and Biological Evaluation
  Journal of Medicinal Chemistry, 2011
• Histone deacetylases in skeletal development and bone mass maintenance
  Gene, 2011
• In Vitro and In Vivo Osteogenic Activity of Largazole
  ACS Medicinal Chemistry Letters, 2011
• Delayed Correlation of mRNA and Protein Expression in Rapamycin-treated Cells and a Role for Ggc1 in Cellular Sensitivity to Rapamycin
  Molecular & Cellular Proteomics, 2010
• Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis
  Rheumatology, 2009
• Down‐regulation of myeloid cell leukemia 1 by epigallocatechin‐3‐gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor α–induced apoptosis
  Arthritis & Rheumatism, 2009
• Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
  Proceedings of the National Academy of Sciences, 2008
• Total Synthesis and Biological Mode of Action of Largazole: A Potent Class I Histone Deacetylase Inhibitor
  Journal of the American Chemical Society, 2008
• Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
  Proceedings of the National Academy of Sciences, 2007